With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
In Durban, South Africa, thousands are currently gathered at the International AIDS Conference to share, learn, teach, and advocate for ending the AIDS epidemic by 2030. This global goal, advanced in 2014 by UNAIDS, is now supported by all major players in the fight against HIV/AIDS.
From the superbug scare in Pennsylvania last month to the UK’s recently released Review on Antimicrobial Resistance, slowing the rate at which infections become resistant to antibiotics is rising up the list of global health priorities—and rightfully so. The Review estimates that deaths from antimicrobial resistance (AMR) could reach 10 million people a year by 2050 if we don’t reduce the overuse and misuse of antimicrobials, including antibiotics, and that the economic damage could add up to a staggering $100 trillion by 2050.
More than 5000 international personalities and technical experts are wrapping up the Women Deliver Conference in Copenhagen this week. The topic: how to empower women, reduce gender inequality, and improve the sexual and reproductive health of women and girls in low- and middle-income countries. Family planning and reproductive health commodities are central to this broader agenda. Yet according to our onsite sources, the conference has barely (if at all) remarked on the funding cuts that UNFPA, the United Nations Population Fund, has experienced since last year.
At the World Bank’s Annual Universal Health Coverage (UHC) Financing Forum this year, I took part in a mock competition to help determine the topic of next year’s forum. I was up against Larry Gostin, who argued that the 2017 forum should focus on equity and human rights, and Sara Bennett, who made the case for it to be the political economy. My pitch was for the forum to focus on efficiency—or value for money—in UHC reforms, and here’s why.
Imagine if a small cut could evolve into a lengthy hospital stay, or worse; if doctors refused to perform surgery or transplants due to prohibitive risk during recovery; and if our collective gains against the world’s biggest infectious killers—HIV, malaria, tuberculosis, sexually transmitted infections, pneumonia, and more—slowed, stalled, and reversed. These nightmare scenarios could become the new global reality if common pathogens evolve to withstand and survive treatment with antimicrobial drugs, a phenomenon known as antimicrobial resistance (AMR).
In an election year, it can start to seem like every policy issue qualifies as contentious. Perhaps that’s why the constructive, bipartisan discussion featured in last week’s Senate Foreign Relations Subcommittee hearing on the West Africa Ebola epidemic was so refreshing.
In the coming week, a series of high-level meetings will thrust mental health into the spotlight of the development world. Five days of events (listed below), centered around the World Bank annual spring meeting, will bring the topic of mental health in low- and middle-income countries to a wider audience than it has ever reached.
When it comes to the challenge of ensuring access to medicines in developing countries, three distinct issues often get conflated: innovation, availability, and affordability. Recent research from CGD alums offers new insight into the complicated dynamics at play at the core of a hot debate.
Our recent report on next generation financing models looks at how global health donors, specifically the Global Fund to Fight AIDS, Tuberculosis and Malaria, can enhance the health impact of grants by tying grant payments to achieved and verified results. Yet there are several ways to condition payments on performance, and some ways would likely work better than others. Can economic theory suggest specific features of contract designs which would generate more health for the money?